Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.62 USD | +1.63% | +0.34% | -8.88% |
12/04 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
04/04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.88% | 593M | |
+22.81% | 46.81B | |
+46.90% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- AVTE Stock
- News Aerovate Therapeutics, Inc.
- Aerovate Therapeutics : Wedbush Sees Aerovate's Drug Candidate AV-101 Generating Annual Revenue of Over $1 Billion